Celyad Oncology SA CYAD Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Europe
EU
Celyad Oncology SA (CYAD)
Celyad Oncology SA (CYAD) Financials

Celyad Oncology SA (CYAD)

0.65

-0.02

(-2.99%)

Closed November 26 10:30AM

Delayed by 15 minutes

Statistics

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Return on Assets (%)	-15.825	-52.113	-43.539	-31.099	-22.068	-36.311	-82.15	-46.936
Return on Equity (%)	-23.331	-81.484	-72.586	-56.581	-44.911	-71.046	-170.719	-159.081
Return on Invested Capital (%)	-24.454	-72.535	-76.241	-59.546	-47.304	-78.45	-26.229	-360.179
Operating Margin (%)	-275.76	-1589.04	-1199.518	-471600	-338140	N/A	N/A	-8263.725
Net Profit Margin (%)	-276.968	-1593.079	-1201.509	-477200	-344080	N/A	N/A	-8282.353
Book Value Per Share	4.437	1.117	1.627	0.676	-0.371	0.331	0.153	0.143
Earnings Per Share	-2.535	-5.716	-3.134	-2.054	-1.234	-1.173	-1.812	-0.204
Cash Per Share	5.192	2.357	3.395	2.822	1.236	1.329	0.551	0.169
Working Capital Per Share	7.956	2.883	3.521	2.217	0.565	0.906	0.195	0.198
Operating Profit Per Share	1.444	0.573	0.351	0.4	1.002	0.255	1.066	0.035
EBIT Per Share	-2.535	-5.716	-3.134	-2.054	-1.234	-1.173	-1.809	-0.205
EBITDA Per Share	-2.535	-5.716	-3.134	-2.054	-1.234	-1.173	-1.809	-0.205
Free Cash Flow Per Share	-2.506	-5.802	-3.08	-2.137	-1.342	-1.223	-1.87	-0.201

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	9.31M	9.87M	11.94M	13.94M	13.94M	22.59M	22.59M	41.43M

Key Stats and Ratios

Market Cap	27.76M
Price to Earnings Ratio	-3.19
Price to Sales Ratio	260
Price to Cash Ratio	3.84
Price to Book Ratio	4.27
Dividend Yield	-

Share Statistics

Shares Outstanding	41.43M
Average Volume (1 week)	23.6k
Average Volume (1 Month)	200.54k
52 Week Change	32.38%
52 Week High	1.22
52 Week Low	0.212

More Ratios Coming Soon!

Celyad Oncology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions